Frazier Life Sciences Management, L.P.
Q3 2026 13F filing
Updated 6 days ago44 disclosed positions worth $4B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | M MIRUM PHARMACEUTICALS INC | $656.5M | 7.68M | 16.29% | — |
| 2 | N NEWAMSTERDAM PHARMA COMPANY | $461.8M | 18.99M | 11.46% | — |
| 3 | E ERASCA INC | $432.1M | 29.48M | 10.72% | — |
| 4 | M MBX BIOSCIENCES INC | $389.9M | 6.65M | 9.67% | — |
| 5 | A ARCUTIS BIOTHERAPEUTICS INC | $261M | 9.87M | 6.47% | — |
| 6 | M MAZE THERAPEUTICS INC | $143.6M | 5.28M | 3.56% | — |
| 7 | T TREVI THERAPEUTICS INC | $136.6M | 9.54M | 3.39% | — |
| 8 | K KRYSTAL BIOTECH INC | $130.1M | 391.3K | 3.23% | — |
| 9 | P PALVELLA THERAPEUTICS INC NE | $121.7M | 882.4K | 3.02% | — |
| 10 | ? N/A ATTOVIA THERAPEUTICS INC | $120.8M | 7.05M | 3.00% | — |
| 11 | ? N/A BRAVEHEART BIO INC | $106.4M | 5.27M | 2.64% | — |
| 12 | P PHATHOM PHARMACEUTICALS INC | $91M | 12.47M | 2.26% | — |
| 13 | P PARABILIS MEDICINES INC | $75.3M | 2.33M | 1.87% | — |
| 14 | D DYNE THERAPEUTICS INC | $62.1M | 3.85M | 1.54% | — |
| 15 | A ACHIEVE LIFE SCIENCE INC | $61.6M | 7.61M | 1.53% | — |
| 16 | M MANNKIND CORP | $61.4M | 15.76M | 1.52% | — |
| 17 | I DISC MEDICINE INC | $61.2M | 934.9K | 1.52% | — |
| 18 | T TARSUS PHARMACEUTICALS INC | $56.6M | 720.3K | 1.40% | — |
| 19 | V VOR BIOPHARMA INC | $52.4M | 2.74M | 1.30% | — |
| 20 | A ASCENDIS PHARMA A/S | $51.3M | 225.2K | 1.27% | — |
| 21 | Z ZAI LAB LTD | $50.1M | 1.90M | 1.24% | — |
| 22 | A ACLARIS THERAPEUTICS INC | $45.9M | 8.73M | 1.14% | — |
| 23 | A AURA BIOSCIENCES INC | $44.6M | 7.10M | 1.11% | — |
| 24 | A ALLOGENE THERAPEUTICS INC | $35.9M | 22.45M | 0.89% | — |
| 25 | B BIOCRYST PHARMACEUTICALS INC | $33.4M | 4.01M | 0.83% | — |
| 26 | C CELLDEX THERAPEUTICS INC NEW | $29.2M | 900.1K | 0.72% | — |
| 27 | A ACADIA PHARMACEUTICALS INC | $29M | 1.44M | 0.72% | — |
| 28 | S SHATTUCK LABS INC | $25.6M | 3.75M | 0.63% | — |
| 29 | I IMMUNOCORE HLDGS PLC | $25.1M | 829.8K | 0.62% | — |
| 30 | D DESIGN THERAPEUTICS INC | $22.7M | 1.81M | 0.56% | — |
| 31 | E EVOLUS INC | $21M | 2.63M | 0.52% | — |
| 32 | S SAREPTA THERAPEUTICS INC | $19.5M | 1.07M | 0.48% | — |
| 33 | R RELAY THERAPEUTICS INC | $18.3M | 1.02M | 0.45% | — |
| 34 | ? N/A LEXEO THERAPEUTICS INC | $16.3M | 4.82M | 0.40% | — |
| 35 | V VALNEVA SE | $14.2M | 2.29M | 0.35% | — |
| 36 | K KAILERA THERAPEUTICS INC | $13.7M | 1.20M | 0.34% | — |
| 37 | M MONTE ROSA THERAPEUTICS INC | $11.9M | 1.00M | 0.30% | — |
| 38 | O ORIC PHARMACEUTICALS INC | $10.1M | 751.7K | 0.25% | — |
| 39 | A AUTOLUS THERAPEUTICS LTD | $8.6M | 4.45M | 0.21% | — |
| 40 | N NEWAMSTERDAM PHARMA COMPANY | $6.3M | 500.3K | 0.16% | — |
| 41 | S SAVARA INC | $5.7M | 1.11M | 0.14% | — |
| 42 | ? N/A XILIO THERAPEUTICS INC | $3.8M | 422.5K | 0.09% | — |
| 43 | ? N/A TCGX ACQUISITION CORP | $3.8M | 300.0K | 0.09% | — |
| 44 | ? N/A IBIO INC | $2.3M | 1.95M | 0.06% | — |